In prostate cancer, prostate brachytherapy boost improves biochemical failure at 10 years but does not prolong long-term OS ...

Click to share on Facebook (Opens in new window) Click to share on X (Opens in new window) Click to email a link to a friend (Opens in new window) Click to print (Opens in new window) Prostate cancer ...

In today’s fast-paced world, men often face health challenges that significantly affect their quality of life. One common issue that many men experience is related to prostate health, leading to ...

Incontinence and other urinary problems after prostate cancer treatment can be eased with Kegel exercises, bladder training, ...

At a median follow-up of 21.5 months, ADT plus apalutamide significantly prolonged median PSA progression-free survival compared with ADT monotherapy (24.9 vs 20.3 months; hazard ratio [HR], 0.52).

Nocturia, a condition characterized by waking up multiple times during the night to use the bathroom, occurs in about one-third of men over the age of 30. As they age, men become even more likely to ...

A plant-based diet combined with probiotics reduces PSA increase in men and lowers prostate cancer risk by 3x.

At 7.3 years’ median follow-up, cabazitaxel failed to improve clinical PFS (62.8% vs 67.2%), metastasis-free survival, or overall survival versus androgen deprivation therapy plus radiotherapy.

November 5, 2009 (Chicago, Illinois) — Anticoagulants are indicated for the treatment of cardiovascular disease but might have a role to play in prostate cancer. Anticoagulants, including aspirin, ...

In the quest for optimal health, especially concerning prostate wellness, men often find themselves overwhelmed with options that claim to deliver results. This is where Total Control 24 comes into ...

Researchers announced in February 2026 that small fragments of plastic were found in nine out of 10 prostate tumor samples, adding new urgency to a growing body of evidence connecting everyday plastic ...

Hemoglobin A 1c (HbA 1c) levels prior to radical prostatectomy (RP) may predict tumor aggressiveness in prostate cancer patients with diabetes, Korean researchers reported in The Prostate (2009;69:820 ...